Marie Louise De Bruin (Marie L De Bruin)

Scopus Author ID ResearcherID Scopus Author ID Researcher ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Topics

Oral Anticoagulants

Atrial Fibrillation

Top Venues

Clinical pharmacology and therapeutics

Pharmacoepidemiology and drug safety

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Sharon C M Essink, Inge M Zomerdijk, Sabine M J M Straus, Helga Gardarsdottir, Marie Louise De Bruin
Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021. Drug safety (2023)
Ann-Katrine Birkelund Mogensen, Helle Christiansen, Marie Louise De Bruin, Christine Erikstrup Hallgreen
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products. Paediatric drugs 24 (6) (2022)
Hendrika A van den Ham, Patrick C Souverein, Olaf H Klungel, Robert W Platt, Pierre Ernst, Sophie Dell'Aniello, Sven Schmiedl, Birgit Grave, Marietta Rottenkolber, Consuelo Huerta, Elisa Martín Merino, Luz M León-Muñoz, Dolores Montero, Morten Andersen, Mia Aakjaer, Marie Louise De Bruin, Helga Gardarsdottir
Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies. Pharmacoepidemiology and drug safety 30 (10) (2021)
Mia Aakjær, Marie Louise De Bruin, Murat Kulahci, Morten Andersen
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data. Drug safety 44 (11) (2021)
Patrick C Souverein, Hendrika A van den Ham, Consuelo Huerta-Álvarez, Elisa Martín Merino, Dolores Montero, Luz M León-Muñoz, Sven Schmiedl, Andreas Heeke, Marietta Rottenkolber, Morten Andersen, Mia Aakjaer, Marie Louise De Bruin, Olaf H Klungel, Helga Gardarsdottir
Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation. British journal of clinical pharmacology 87 (3) (2020)
Marc Maliepaard, Timi Toiviainen, Marie Louise De Bruin, Didier Meulendijks
Pharmacogenetic-Pharmacokinetic Interactions in Drug Marketing Authorization Applications via the European Medicines Agency Between 2014 and 2017. Clinical pharmacology and therapeutics 108 (2) (2020)
Alice L Bhasale, Ameet Sarpatwari, Marie Louise De Bruin, Joel R Lexchin, Ruth Lopert, Priya Bahri, Barbara J Mintzes
Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States. Clinical pharmacology and therapeutics 109 (6) (2020)
Louise C Druedahl, Anna Birna Almarsdóttir, Sofia Kälvemark Sporrong, Marie Louise De Bruin, Hans Hoogland, Timo Minssen, Marco van de Weert, Aaron S Kesselheim, Ameet Sarpatwari
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways. Nature biotechnology 38 (11) (2020)
Per Sindahl, Christian Overgaard-Steensen, Helle Wallach-Kildemoes, Marie Louise De Bruin, Hubert Gm Leufkens, Kaare Kemp, Helga Gardarsdottir
Are Further Interventions Needed to Prevent and Manage Hospital-Acquired Hyponatraemia? A Nationwide Cross-Sectional Survey of IV Fluid Prescribing Practices. Journal of clinical medicine 9 (9) (2020)
Maja-Marie Grønfeldt Højer, Marie Louise De Bruin, Arnela Boskovic, Christine Erikstrup Hallgreen
Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018. BMJ open 10 (5) (2020)
Annemieke W J Opstal-van Winden, Hugoline G de Haan, Michael Hauptmann, Marjanka K Schmidt, Annegien Broeks, Nicola S Russell, Cécile P M Janus, Augustinus D G Krol, Frederieke H van der Baan, Marie Louise De Bruin, Anna M van Eggermond, Joe G Dennis, Hoda Anton-Culver, Christopher A Haiman, Elinor J Sawyer, Angela Cox, Peter Devilee, Maartje J Hooning, Julian Peto, Fergus J Couch, Paul David Peter Pharoah, Nick Orr, Douglas F Easton, Berthe M P Aleman, Louise C Strong, Smita Bhatia, Rosie Cooke, Leslie L Robison, Anthony J Swerdlow, Flora E van Leeuwen
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. Blood 133 (10) (2018)
Jacoline C Bouvy, Kevin Blake, Jim Slattery, Marie Louise De Bruin, Peter Arlett, Xavier Kurz
Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013. Pharmacoepidemiology and drug safety 26 (12) (2017)